New York 2025-2026 Regular Session

New York Senate Bill S08925

Introduced

1/16/26

Refer

1/16/26

Caption

Prohibits the sale of products that contain 7-hydroxymitragynine at a level that exceeds 2% of total alkaloids or one milligram per serving; establishes fines for the sale of such products.

Impact

If passed, this legislation would bring significant changes to the existing General Business Law in New York. The new stipulations would apply to all forms of sale, delivery, or distribution of 7-hydroxymitragynine products within the state. Violators of this law would be subject to civil penalties, with fines reaching up to $3,000 for initial offenses and $6,500 for subsequent violations. The collected funds from these penalties are to be directly deposited into the state drug treatment and public education fund, thus linking enforcement action with community health initiatives.

Summary

Bill S08925 aims to prohibit the sale of products containing 7-hydroxymitragynine at levels exceeding 2% of total alkaloids or one milligram per serving. This bill addresses growing concerns about the safety and regulation of such products, which are often marketed as natural supplements. By defining specific limits on the alkaloid content, the bill seeks to mitigate potential health risks associated with higher concentrations of this compound, which is derived from the kratom plant and has gained popularity for its purported effects.

Contention

There is potential for contention surrounding this legislation, particularly from consumers and businesses involved in the kratom market. Advocates for the bill argue that it is necessary for consumer safety and public health, as there are worries about the unregulated nature of the products currently available. However, opponents may argue that the prohibition could infringe on personal freedoms and access to alternative remedies. Additionally, the financial impact on businesses that sell these products could lead to discussions around economic considerations versus health regulations.

Companion Bills

NY A09156

Same As Prohibits the sale of products that contain 7-hydroxymitragynine at a level that exceeds 2% of total alkaloids or one milligram per serving; establishes fines for the sale of such products.

Previously Filed As

NY A09156

Prohibits the sale of products that contain 7-hydroxymitragynine at a level that exceeds 2% of total alkaloids or one milligram per serving; establishes fines for the sale of such products.

NY S08686

Prohibits the sale or offering for sale, delivery or manufacture of food or beverages containing kratom or its derivatives, or 7-hydroxymitragynine; provides penalties.

NY A09114

Prohibits the sale or offering for sale, delivery or manufacture of food or beverages containing kratom or its derivatives, or 7-hydroxymitragynine; provides penalties.

NY A1636

Classifies 7 Hydroxymitragynine as Schedule I drug and bans sale of products containing substance.

NY S09073

Prohibits the sale of certain products that contain regulated perfluoroalkyl and polyfluoroalkyl substances; requires manufacturers of products containing PFAS to provide notice of such fact to persons that offer the products for sale or distribution; provides penalties for violations.

NY A09105

Includes certain land that is owned or rented as a farm operation for the production for sale of crops, livestock or livestock products as land used in agricultural production.

NY S00593

Includes certain land that is owned or rented as a farm operation for the production for sale of crops, livestock or livestock products as land used in agricultural production.

NY A07738

NY A10969

Enacts the "synthetic kratom kills act" to prohibit harmful synthetic and adulterated kratom products; provides that no person, manufacturer, retailer, or other entity shall manufacture, distribute, sell, or offer for sale: synthesized kratom material; any adulterated kratom product; a kratom product that is combustible or intended to be used for vaporization, aerosolization, or injection; a kratom product that is incorporated into, or marketed or labeled as, a conventional food or beverage product; a kratom product that contains flavoring agents or additives specifically designed or marketed to appeal to individuals under twenty-one years of age; a kratom product not contained in child-resistant packaging; a kratom product that mimics a candy product or is manufactured, packaged, or advertised in a way that can be reasonably considered to appeal to individuals under twenty-one years of age; any kratom product to an individual under twenty-one years of age; and any kratom product in which the concentration of 7-hydroxymitragynine exceeds two percent of the concentration of total alkaloids; requires testing and clear labeling.

NY A08585

Phases out the sale of products that contain intentionally added PFAS.

Similar Bills

No similar bills found.